Leukaemia, along with other malignant blood disorders, is one of the biggest challenges in the study and treatment of cancer in humans. For some time it has been one of the curable forms of cancer, so it is not surprising that currently the two cancers from which a large percentage of patients recover are acute lymphoblastic leukaemia (ALL) in children and Hodgkin’s lymphoma. However, one in four children with leukaemia die, as well as half of adult patients.
That is why the José Carreras International Foundation, together with the government, is launching an unprecedented project: the first research centre in Spain focusing exclusively on leukaemia and other haematological diseases, and one of the few such centres in the world.
Commitment to patients is the raison d’être of the Josep Carreras Leukemia Research Institute and, as such, it is imperative to strengthen efforts already being made in scientific research focused on leukaemia and other malignant blood disorders.
